trending Market Intelligence /marketintelligence/en/news-insights/trending/Nm4_vlDIxkMjKRzow2UM3w2 content esgSubNav
In This List

RedHawk completes share transfer deal for generic maker EcoGen

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


RedHawk completes share transfer deal for generic maker EcoGen

RedHawk Holdings Corp. said it now holds 75% of common shares of privately-held generic maker EcoGen Europe LTD.

Louisiana-based RedHawk and its unit RedHawk Pharma UK Ltd. completed a share transfer agreement with U.K.-based Scarlett Pharma Ltd and its affiliate.

Under the deal, Scarlett and its unit transferred about $545,000 worth of preference shares and 75% of common shares in EcoGen to RedHawk.

RedHawk said it was evaluating the possibility of converting its EcoGen preference shares into additional common shares to further raise its common stock ownership in EcoGen.